Pertussis Vaccine Global Market Report 2024

Description

“Pertussis Vaccine Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pertussis vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pertussis vaccine? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pertussis vaccine market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Product Type: DTaP (Diphtheria, Tetanus and Acellular Pertussis) Vaccine; Tdap (Tetanus, Diphtheria and Pertussis) Vaccine
2) By Vaccine Type: Whole-Cell Vaccine; Acellular Vaccine
3) By Application: Children; Adults; Infants
4) By End-User: Vaccination Centers; Hospitals; Clinics
Companies Mentioned: Pfizer Inc.; Johnson And Johnson Pvt Ltd.; Merck And Co. Inc.; Novartis AG; GlaxoSmithKline plc
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

The pertussis vaccine is a vaccination designed to provide protection against whooping cough (pertussis), a highly contagious respiratory disease caused by the bacterium Bordetella pertussis. Its purpose is to stimulate the immune system to generate protective antibodies against the pertussis bacterium, thus reducing the risk of infection and the associated symptoms.

The main products related to the pertussis vaccine include the DTaP (diphtheria, tetanus, and acellular pertussis) vaccine and the Tdap (tetanus, diphtheria, and pertussis) vaccine. The DTaP vaccine, which is also known as the DTP vaccine, is a combination vaccine intended to safeguard against three serious bacterial infections such as diphtheria, tetanus, and pertussis (whooping cough). These vaccines are available in both whole-cell and acellular formulations and are administered to individuals of various age groups, including children, adults, and infants. They are typically administered by healthcare professionals at vaccination centers, hospitals, and clinics.

The pertussis vaccine market research report is one of a series of new reports from The Business Research Company that provides pertussis vaccine market statistics, including pertussis vaccine industry global market size, regional shares, competitors with a pertussis vaccine market share, detailed pertussis vaccine market segments, market trends and opportunities and any further data you may need to thrive in the pertussis vaccine industry. This pertussis vaccine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pertussis vaccine market size has grown steadily in recent years. It will grow from $5.26 billion in 2023 to $5.5 billion in 2024 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to disease prevalence, immunization programs, pediatric vaccination, regulatory approvals.

The pertussis vaccine market size is expected to see steady growth in the next few years. It will grow to $6.33 billion in 2028 at a compound annual growth rate (CAGR) of 3.6%. The growth in the forecast period can be attributed to booster vaccination, maternal immunization, immunization for healthcare workers, global health initiatives. Major trends in the forecast period include personalized immunization schedules, combination vaccines, vaccine equity initiatives, digital health for immunization.

The upward trend in childbirth rates is expected to be a significant growth driver for the pertussis vaccine market. Childbirth is the natural process of bringing a child into the world, marking the end of pregnancy and the beginning of a new life. The pertussis vaccine primarily targets children to provide protection against whooping cough and other severe, potentially life-threatening illnesses. For example, in May 2022, the U.S.-based Center for Disease Control and Prevention (CDC) reported 3.66 million births in the United States in 2021, a slight increase from 3.61 million in 2020. Additionally, in 2021, Canada, as per Statistics Canada, recorded a 2% rise in births, with numbers increasing from 360,552 in 2020 to 367,684 in 2021. Hence, the growing prevalence of childbirth rates is a significant factor propelling the expansion of the pertussis vaccine market.

The continuous growth of the geriatric population is anticipated to drive the expansion of the pertussis vaccine market. The geriatric population encompasses individuals in their later stages of life, typically aged 65 and older. The expanding number of older adults is a key contributor to the pertussis vaccine market. As more people enjoy longer lifespans, there is a heightened demand for pertussis vaccines to protect older individuals from this serious disease. For instance, in October 2022, the Switzerland-based World Health Organization projected that the global population of individuals aged 60 years and above is set to double by 2050, reaching 2.1 billion. Simultaneously, the number of individuals aged 80 years or older is expected to triple from 2020 to 2050, totaling 426 million. Consequently, the growing geriatric population is fostering the growth of the pertussis vaccine market.

The restricted availability of pertussis vaccines acts as a constraining factor on the growth of the pertussis vaccines market during the projected period. The limited accessibility to pertussis vaccines has resulted in adverse effects on their distribution and effectiveness, including constrained vaccine accessibility, escalated costs, decreased demand, delayed or incomplete immunization, and global ramifications. For instance, in July 2023, UNICEF (United Nations International Children's Emergency Fund) reported that approximately 14.3 million children did not receive any doses of pertussis vaccines (diphtheria-tetanus-pertussis DTP3) in 2022. Hence, this limited availability is impeding the expansion of the pertussis vaccines market.

Major enterprises engaged in the pertussis vaccine market are actively advancing innovative vaccines and securing regulatory approvals to maintain their market position. For instance, in October 2022, GSK plc., a UK-based pharmaceutical and biotechnology company, announced the U.S. Food and Drug Administration (FDA) approval of BOOSTRIX. BOOSTRIX is a tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine adsorbed (Tdap) vaccine. It is administered during pregnancy to prevent pertussis (whooping cough) in newborn infants and is administered as a single upper arm muscle injection. Boostrix is recognized for its safety and effectiveness in pregnant women and their infants, effectively preventing pertussis, including severe cases of the disease.

In May 2022, GSK plc., a UK-based pharmaceutical and biotechnology company, completed the acquisition of Affinivax Inc. for a sum of $2.1 billion. This strategic acquisition is a step taken by GSK to broaden its vaccine portfolio, enhance its outreach to patients, bolster its vaccine research and development pipeline, gain access to a potentially groundbreaking technology, and expand its scientific presence in the Boston region. Affinivax Inc. is a U.S.-based biotechnology enterprise specialized in the development of pertussis vaccines.

Major players in the pertussis vaccine market are Pfizer Inc., Johnson And Johnson Pvt Ltd., Merck And Co. Inc., Novartis AG, GlaxoSmithKline PLC, AstraZeneca PLC, BioNTech SE, Moderna Inc., Sinovac Biotech Ltd., CSL Limited, Astellas Pharma US Inc., Sanofi Pasteur SA, Mitsubishi Tanabe Pharma America Inc., PT Kalbe Farma Tbk, CSL Seqirus, Walvax Biotechnology Co.Ltd., Biological E. Limited, Serum Institute of India, Bavarian Nordic AS, PT Bio Farma, Bharat Biotech International Limited, Takeda Pharmaceutical Company, Panacea Biotec Limited, Beijing Minhai Biotechnology Co. Ltd., Protein Sciences Corporation, Wuhan Institute of Biological Products, Changchun Changsheng Life Sciences, Changsheng Bio-Technology Co. Ltd., Gennova Biopharmaceuticals Ltd., Chiron Corporation .

North America was the largest region in the pertussis vaccine market in 2023. The regions covered in pertussis vaccine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pertussis vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pertussis vaccine market consists of sales of adacel, daptacel, infanrix, kinrix, pediarix, pentacel and quadracel. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12369

1. Executive Summary

2. Pertussis Vaccine Market Characteristics

3. Pertussis Vaccine Market Trends And Strategies

4. Pertussis Vaccine Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Pertussis Vaccine Market Size and Growth

5.1. Global Pertussis Vaccine Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Pertussis Vaccine Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Pertussis Vaccine Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Pertussis Vaccine Market Segmentation

6.1. Global Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
DTaP (Diphtheria, Tetanus, And Acellular Pertussis) Vaccine
Tdap (Tetanus, Diphtheria, And Pertussis) Vaccine
6.2. Global Pertussis Vaccine Market, Segmentation By Vaccine Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Whole-Cell Vaccine
Acellular Vaccine
6.3. Global Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Children
Adults
Infants
6.4. Global Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Vaccination Centers
Hospitals
Clinics

7. Pertussis Vaccine Market Regional And Country Analysis

7.1. Global Pertussis Vaccine Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Pertussis Vaccine Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Pertussis Vaccine Market

8.1. Asia-Pacific Pertussis Vaccine Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Pertussis Vaccine Market

9.1. China Pertussis Vaccine Market Overview
9.2. China Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Pertussis Vaccine Market

10.1. India Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Pertussis Vaccine Market

11.1. Japan Pertussis Vaccine Market Overview
11.2. Japan Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Pertussis Vaccine Market

12.1. Australia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Pertussis Vaccine Market

13.1. Indonesia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Pertussis Vaccine Market

14.1. South Korea Pertussis Vaccine Market Overview
14.2. South Korea Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Pertussis Vaccine Market

15.1. Western Europe Pertussis Vaccine Market Overview
15.2. Western Europe Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Pertussis Vaccine Market

16.1. UK Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Pertussis Vaccine Market

17.1. Germany Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Pertussis Vaccine Market

18.1. France Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Pertussis Vaccine Market

19.1. Italy Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Pertussis Vaccine Market

20.1. Spain Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Pertussis Vaccine Market

21.1. Eastern Europe Pertussis Vaccine Market Overview
21.2. Eastern Europe Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Pertussis Vaccine Market

22.1. Russia Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Pertussis Vaccine Market

23.1. North America Pertussis Vaccine Market Overview
23.2. North America Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Pertussis Vaccine Market

24.1. USA Pertussis Vaccine Market Overview
24.2. USA Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Pertussis Vaccine Market

25.1. Canada Pertussis Vaccine Market Overview
25.2. Canada Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Pertussis Vaccine Market

26.1. South America Pertussis Vaccine Market Overview
26.2. South America Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Pertussis Vaccine Market

27.1. Brazil Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Pertussis Vaccine Market

28.1. Middle East Pertussis Vaccine Market Overview
28.2. Middle East Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Pertussis Vaccine Market

29.1. Africa Pertussis Vaccine Market Overview
29.2. Africa Pertussis Vaccine Market, Segmentation By Product Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Pertussis Vaccine Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Pertussis Vaccine Market, Segmentation By End-User , Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Pertussis Vaccine Market Competitive Landscape And Company Profiles

30.1. Pertussis Vaccine Market Competitive Landscape
30.2. Pertussis Vaccine Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson And Johnson Pvt Ltd.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck And Co. Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. GlaxoSmithKline plc
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Pertussis Vaccine Market Other Major And Innovative Companies

31.1. AstraZeneca plc
31.2. BioNTech SE
31.3. Moderna Inc.
31.4. Sinovac Biotech Ltd.
31.5. CSL Limited
31.6. Astellas Pharma US Inc.
31.7. Sanofi Pasteur SA
31.8. Mitsubishi Tanabe Pharma America Inc.
31.9. PT Kalbe Farma Tbk
31.10. CSL Seqirus
31.11. Walvax Biotechnology Co.Ltd.
31.12. Biological E. Limited
31.13. Serum Institute of India
31.14. Bavarian Nordic AS
31.15. PT Bio Farma

32. Global Pertussis Vaccine Market Competitive Benchmarking

33. Global Pertussis Vaccine Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Pertussis Vaccine Market

35. Pertussis Vaccine Market Future Outlook and Potential Analysis

35.1 Pertussis Vaccine Market In 2028 - Countries Offering Most New Opportunities
35.2 Pertussis Vaccine Market In 2028 - Segments Offering Most New Opportunities
35.3 Pertussis Vaccine Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer